About SPRAVATO® for Treatment-Resistant Depression (TRD)
- Proven efficacy with a consistent safety profile1,2
- Safety evaluated in over 1700 adults with treatment-resistant depression (TRD) across six studies: Five Phase 3 studies and one Phase 2 dose ranging study2
